Syros Shares Soar As FDA Grants Orphan Drug Status To Pancreatic Cancer Candidate
September 13, 2022 at 16:23 PM EDT
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Syros Pharmaceuticals (NASDAQ: SYRS) lead candidate ...
